Trial comparing treatments for Localized Non-Muscle Invasive Bladder Urothelial Carcinoma
Official title Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
ClinicalTrials.gov ID: NCT07302230
What this study is testing
- What it's testing
- The study wants to see if a personalized exercise program delivered through a digital app can increase daily activity more than standard health education.
- Who it's for
- Adults diagnosed with non‑muscle invasive bladder cancer who are not currently active.
- What's involved
- Participants will use the ExerciseRx app, which sets step goals, tracks progress, and gives feedback, while the comparison group receives only health‑education materials.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (age \>= 18 years)
- Prior diagnosis of non-muscle invasive bladder cancer (NMIBC), currently on surveillance or receiving maintenance intravesical therapy (including...
- Classified as insufficiently active on the Physical Activity as a Vital Sign (PAVS) assessment
- Has an Android or Apple Smartphone/Tablet
- Ambulatory
You likely can't join if
- Severe cognitive or memory impairment/dementia precluding ability to follow instructions or participate in survey assessments
- Inability to read or understand English
- Lack of access or lack of sufficient facility to use an Android or iOS smart device with the minimum criteria to run the ExerciseRx app
- Not receiving treatment at University of Washington (UW)
- Orthopedic, neurologic, or other problems that prevent safe ambulation and protocol adherence.
- Inability/Unwillingness to participate in a personalized exercise program
See the full eligibility criteria
- Adults (age \>= 18 years)
- Prior diagnosis of non-muscle invasive bladder cancer (NMIBC), currently on surveillance or receiving maintenance intravesical therapy (including intravesical chemotherapy, immunotherapy)
- Classified as insufficiently active on the Physical Activity as a Vital Sign (PAVS) assessment
- Has an Android or Apple Smartphone/Tablet
- Ambulatory
- English-speaking
- Willing and able to participate in study activities and sign the informed consent form
- Severe cognitive or memory impairment/dementia precluding ability to follow instructions or participate in survey assessments
- Inability to read or understand English
- Lack of access or lack of sufficient facility to use an Android or iOS smart device with the minimum criteria to run the ExerciseRx app
- Not receiving treatment at University of Washington (UW)
- Orthopedic, neurologic, or other problems that prevent safe ambulation and protocol adherence. Information on prior falls and other recent orthopedic or neurologic problems will be used to make judgment about protocol...
- Inability/Unwillingness to participate in a personalized exercise program
- Current diagnosis with muscle-invasive or metastatic bladder cancer
- Uncontrolled or concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations...
- Lack of access or lack of sufficient facility to use an Android or iOS smart device with the minimum criteria for using the ExerciseRx app
- Participation in a clinical trial that does not permit enrollment in the EMPOWER trial
The study team makes the final eligibility decision.
Where it is enrolling
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.